相关实验视频
Updated: Jul 19, 2025

06:45
Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
15.3K
阿佩林受体的分化和寡合化
Mahboobeh Yeganeh-Hajahmadi1, Yasmin Moosavi-Saeed2, Farzaneh Rostamzadeh3
1Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Current molecular pharmacology
|August 18, 2023
概括
阿佩林受体 (APJ),一种G蛋白结合受体 (GPCR),形成二聚体和寡聚体. 了解APJ寡合化可能会彻底改变药理学,并为糖尿病和高血压等疾病提供新的治疗点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
- 心血管科学 心血管科学
背景情况:
- 阿佩林系统,包括阿佩林及其受体 (APJ),对心血管和液体平衡至关重要.
- APJ与各种疾病有关,包括糖尿病,高血压,肥胖和癌症,使其成为治疗点.
- 包括APJ在内的G蛋白结合受体 (GPCR) 可以形成二聚体和寡聚体,从而影响受体信号传递.
研究的目的:
- 探索阿佩林受体 (APJ) 的二聚化和寡聚化.
- 研究APJ如何与自身和其他受体形成复合体.
- 了解APJ寡合化对其信号通路的影响.
主要方法:
- 关于APJ结构和功能的文献综述.
- 对研究GPCR寡合化的研究进行分析.
- 探索由于APJ复合体形成而导致的信号通路改变.
主要成果:
- 阿佩林受体 (APJ) 具有形成二聚体和寡聚体的能力.
- APJ寡合化可以涉及与其他受体的同型和异型寡合化.
- 受体寡合化与改变的信号通路激活有关.
结论:
- APJ二聚化和寡聚化是其功能的重要方面.
- 对APJ寡合化的进一步研究可能会解锁新的药理学策略.
- 了解这些复杂物是开发新治疗APJ相关疾病的关键.
相关概念视频
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Cytoskeletal Linker Proteins - Plakins
2.3K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.3K
IP3/DAG Signaling Pathway
12.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K

